Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bicalutamide Monotherapy Preserves Bone Mineral Density, Muscle Strength and Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer

NCT00551044 is registered in ClinicalTrials.gov with Wirral University Teaching Hospital NHS Trust as lead sponsor.

NCT NCT00551044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bicalutamide Monotherapy Preserves Bone Mineral Density, Muscle Strength and Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
Lead sponsor
Wirral University Teaching Hospital NHS Trust
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2003
Completion date
August 31, 2005
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms